Live Breaking News & Updates on Prnewswire Halozyme Therapeutics Inc

Stay updated with breaking news from Prnewswire halozyme therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Halozyme to Participate in Upcoming Investor Conferences

/PRNewswire/ Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley, president and chief executive officer, is. ....

United States , San Diego , Eli Lilly , Helen Torley , Samantha Gaspar , Bristol Myers Squibb , Idorsia Pharmaceuticals , Halozyme Therapeutics Inc , Corporate Communications , Teva Pharmaceuticals , Prnewswire Halozyme Therapeutics Inc , Acumen Pharmaceuticals , Annual Healthcare , Partners Global Biopharma Conference , Annual Global Healthcare , Investor Relations , Viiv Healthcare , Chugai Pharmaceutical , Halozyme Therapeutics ,

Halozyme To Report Fourth Quarter and Full Year 2023 Financial and Operating Results

SAN DIEGO, Feb. 8, 2024 /PRNewswire/ Halozyme Therapeutics, Inc. today announced it will release its fourth quarter and full year 2023 financial and operating results on Tuesday, February 20,. ....

San Diego , United States , Samantha Gaspar , Eli Lilly , Teva Pharmaceuticals , Prnewswire Halozyme Therapeutics Inc , Bristol Myers Squibb , Idorsia Pharmaceuticals , Corporate Communications , Halozyme Therapeutics Inc , Horizon Therapeutics , Viiv Healthcare , Investor Relations ,

Halozyme To Report Fourth Quarter and Full Year 2023 Financial and Operating Results

/PRNewswire/ Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its fourth quarter and full year 2023 financial and. ....

San Diego , United States , Samantha Gaspar , Eli Lilly , Bristol Myers Squibb , Prnewswire Halozyme Therapeutics Inc , Halozyme Therapeutics Inc , Corporate Communications , Idorsia Pharmaceuticals , Teva Pharmaceuticals , Horizon Therapeutics , Viiv Healthcare , Investor Relations ,

Halozyme To Report Fourth Quarter and Full Year 2023 Financial and Operating Results

Halozyme To Report Fourth Quarter and Full Year 2023 Financial and Operating Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San Diego , United States , Samantha Gaspar , Eli Lilly , Corporate Communications , Halozyme Therapeutics Inc , Bristol Myers Squibb , Prnewswire Halozyme Therapeutics Inc , Teva Pharmaceuticals , Idorsia Pharmaceuticals , Horizon Therapeutics , Viiv Healthcare , Investor Relations ,

Halozyme Announces Takeda Received European Commission Approval for HYQVIA® Co-formulated with ENHANZE® as Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

SAN DIEGO, Jan. 29, 2024 /PRNewswire/ Halozyme Therapeutics, Inc. today announced that Takeda received European Commission approval for HYQVIA® [Immune Globulin Infusion 10% ] co-formulated. ....

San Diego , United States , Eli Lilly , Helen Torley , Acumen Pharmaceuticals , Exchange Commission , Idorsia Pharmaceuticals , Teva Pharmaceuticals , European Medicines Agency , Drug Administration , Prnewswire Halozyme Therapeutics Inc , Halozyme Therapeutics Inc , Corporate Communications , Bristol Myers Squibb , European Commission , Horizon Therapeutics , Viiv Healthcare , Chugai Pharmaceutical , Annual Report , Quarterly Reports , Investor Relations ,